|
|
- 2018
变应性鼻炎患者血液嗜酸性粒细胞富集群中TLR2、TLR4、TLR7和TLR9的变化及其相关性
|
Abstract:
摘要：目的 探讨变应性鼻炎(AR)患者血液嗜酸性粒细胞富集群中TLR2、TLR4、TLR7和TLR9的变化及其相关性，探索其在AR中的发病机制。方法 收集健康人和AR患者的外周静脉血，用蒿草花粉、尘螨和梧桐花粉过敏原提取液刺激，流式细胞术检测刺激前后嗜酸性粒细胞富集群中TLR2、TLR4、TLR7和TLR9的表达，SPSS软件分析TLR2+、TLR4+、TLR7+和TLR9+嗜酸性粒细胞的相关性。结果 与健康组比较，AR患者未经过敏原刺激时嗜酸性粒细胞富集群中TLR2+细胞的比例降低4%，TLR4+细胞的平均荧光强度(mean fluorescence intensity, MFI)升高20%，TLR7+细胞的比例升高4.8倍。蒿草花粉过敏原提取液诱导AR患者TLR2+嗜酸性粒细胞的比例升高7.8%。此外，AR患者血液TLR2+和TLR4+、TLR2+和TLR7+、TLR7+和TLR9+的嗜酸性粒细胞均呈中度相关(Pearson相关系数分别为r=－0.670，P<0.01；r=－0.430，P<0.05；r=0.446，P<0.05)。而健康人嗜酸性粒细胞富集群中TLR2、TLR4、TLR7和TLR9的变化在过敏原刺激前后差异均无统计学意义。结论 嗜酸性粒细胞源的TLR2、TLR4和TLR7可能在AR中起重要作用，TLR2、TLR4和TLR7可能是治疗AR的潜在靶点。
ABSTRACT: Objective To investigate expressions and correlations of TLR2, TLR4, TLR7 and TLR9 in eosinophil-enriched cell populations from patients with allergic rhinitis (AR), and elucidate their roles in AR. Methods Peripheral venous blood samples were collected from healthy controls (HCs) and AR patients, and then incubated with crude extracts of Artemisia pollen, dust mite, and Platanus pollen, respectively. Levels of TLR2, TLR4, TLR7 and TLR9 in blood eosinophil-enriched cells were detected by flow cytometry. Correlations between TLR2+, TLR4+, TLR7+ and TLR9+ eosinophils were analyzed by SPSS. Results Levels of TLR2+ eosinophils from patients with AR were reduced by 4%, mean fluorescence intensity (MFI) of TLR4+ eosinophil was elevated by 20%, and TLR7+ eosinophils increased up to 4.8 folds compared with HCs when cultured with medium only (P<0.05). Artemisia pollen extracts induced approximately 7.8% of increase in TLR2+ eosinophils from AR patients. In addition, correlations between TLR2+ and TLR4+ eosinophils, TLR2+ and TLR7+ eosinophils, and TLR7+ and TLR9+ eosinophils were -0.670 (P<0.01), -0.430 (P<0.05) and 0.446 (P<0.05), respectively. However, allergens had few effects on TLR2, TLR4, TLR7 and TLR9 expressions in HCs. Conclusion Eosinophil-derived TLR2, TLR4 and TLR7 are likely to play a key role in AR. TLR2, TLR4 and TLR7 might become the potential targets for AR treatment
| [1] | BACHELET I, LEVI-SCHAFFER F. Mast cells as effector cells: A co-stimulating question[J]. Trends Immunol, 2007, 28(8):360-365. |
| [2] | CUI XY, CHEN X, YU CJ, et al. Increased expression of toll-like receptors 2 and 4 and related cytokines in persistent allergic rhinitis[J]. Otolaryngol Head Neck Surg, 2015, 152(2):233-238. |
| [3] | LI X, LIU Y, ZHANG Q, et al, Effect of catgut implantation at acupoints for the treatment of allergic rhinitis: A randomized, sham-controlled trial[J]. BMC Complement Altern Med, 2016, 16(1):454. |
| [4] | HENMYR V, CARLBERG D, MANDERSTEDT E, et al. Genetic variation of the Toll-like receptors in a Swedish allergic rhinitis case population[J]. BMC Med Genet, 2017, 18(1):18. |
| [5] | HE S, MAO X, SUN H, et al. Potential therapeutic targets in the process of nucleic acid recognition: Opportunities and challenges[J]. Trends Pharmacol Sci, 2015, 36(1):51-64. |
| [6] | MOISAN J, CAMATEROS P, THURAISINGAM T, et al. TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway[J]. Am J Physiol Lung Cell Mol Physiol, 2006, 290(5):L987-995. |
| [7] | FRANSSON M, BENSON M, ERJEFALT JS, et al. Expression of Toll-like receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis[J]. Respir Res, 2007, 8:17. |
| [8] | JACOBSEN EA, LEE NA, LEE JJ. Re-defining the unique roles for eosinophils in allergic respiratory inflammation[J]. Clin Exp Allergy, 2014, 44(9):1119-1136. |
| [9] | BOUSQUET J, SCHUNEMANN HJ, FONSECA J, et al. MACVIA-ARIA sentinel network for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation[J]. Allergy, 2015, 70(11):1372-1392. |
| [10] | SMITH DE. The biological paths of IL-1 family members IL-18 and IL-33[J]. J Leukoc Biol, 2011, 89(3):383-392. |
| [11] | THOMAS C, BAZAN JF, GARCIA KC. Structure of the activating IL-1 receptor signaling complex[J]. Nat Struct Mol Biol, 2012, 19(4):455-457. |
| [12] | ARYAN Z, HOLGATE ST, RADZIOCH D, et al. A new era of targeting the ancient gatekeepers of the immune system: Toll-like agonists in the treatment of allergic rhinitis and asthma[J]. Int Arch Allergy Immunol, 2014, 164(1):46-63. |
| [13] | HE SH, ZHANG HY, ZENG XN, et al. Mast cells and basophils are essential for allergies: Mechanisms of allergic inflammation and a proposed procedure for diagnosis[J]. Acta Pharmacol Sin, 2013, 34(10):1270-1283. |
| [14] | THORNTON MA, AKASHEH N, WALSH MT, et al. Eosinophil recruitment to nasal nerves after allergen challenge in allergic rhinitis[J]. Clin Immunol, 2013, 147(1):50-57. |
| [15] | LIU AH. Innate microbial sensors and their relevance to allergy[J]. J Allergy Clin Immunol, 2008, 122(5):846-858. |
| [16] | GAO Z, RENNIE DC, SENTHILSELVAN A. Allergic rhinitis and genetic components: Focus on Toll-like receptors (TLRs) gene polymorphism[J]. Appl Clin Genet, 2010, 3:109-120. |
| [17] | LAINO J, WANGORSCH A, BLANCO F, et al. Targeting of immune cells by dual TLR2/7 ligands suppresses features of allergic Th2 immune responses in mice[J]. J Immunol Res, 2017, 2017:7983217. |
| [18] | MANSSON A, CARDELL LO. Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils[J]. J Leukoc Biol, 2009, 85(4):719-727. |
| [19] | GREIFF L, CERVIN A, AHLSTROM-EMANUELSSON C, et al. Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis[J]. Respir Res, 2012, 13:53. |
| [20] | NILSSON D, ANDIAPPAN AK, HALLDEN C, et al. Toll-like receptor gene polymorphisms are associated with allergic rhinitis: a case control study[J]. BMC Med Genet, 2012, 13:66. |
